Susquehanna International Group, LLP Takeda Pharmaceutical CO LTD Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

A detailed history of Susquehanna International Group, LLP transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Susquehanna International Group, LLP holds 14,292 shares of TAK stock, worth $193,799. This represents 0.0% of its overall portfolio holdings.

Number of Shares

14,292

Holding current value

$193,799

% of portfolio

0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$13.0 - $15.08 $185,796 - $215,523	14,292 New	14,292 $203,000
Q1 2024 May 07, 2024	SELL	$13.89 - $15.04 $389,878 - $422,157	-28,069 Reduced 72.65%	10,569 $146,000
Q4 2023 Feb 14, 2024	BUY	$13.36 - $15.43 $365,035 - $421,593	27,323 Added 241.48%	38,638 $551,000
Q3 2023 Nov 14, 2023	BUY	$15.03 - $16.32 $170,064 - $184,660	11,315 New	11,315 $175,000
Q1 2023 May 16, 2023	SELL	$15.28 - $16.48 $1.29 Million - $1.39 Million	-84,551 Reduced 87.87%	11,668 $192,000
Q4 2022 Feb 14, 2023	BUY	$12.42 - $15.62 $819,645 - $1.03 Million	65,994 Added 218.34%	96,219 $1.5 Million
Q3 2022 Nov 14, 2022	SELL	$12.8 - $28.65 $1.95 Million - $4.36 Million	-152,117 Reduced 83.42%	30,225 $392,000
Q2 2022 Aug 15, 2022	SELL	$13.12 - $15.03 $1.15 Million - $1.31 Million	-87,478 Reduced 32.42%	182,342 $2.56 Million
Q1 2022 May 16, 2022	SELL	$13.54 - $15.35 $3.83 Million - $4.34 Million	-283,045 Reduced 51.2%	269,820 $3.86 Million
Q4 2021 Feb 14, 2022	SELL	$13.17 - $16.4 $7.37 Million - $9.18 Million	-559,943 Reduced 50.32%	552,865 $7.54 Million
Q3 2021 Nov 15, 2021	SELL	$16.3 - $17.26 $292,585 - $309,817	-17,950 Reduced 1.59%	1,112,808 $18.2 Million
Q2 2021 Aug 11, 2021	SELL	$16.55 - $18.64 $6.77 Million - $7.62 Million	-408,827 Reduced 26.55%	1,130,758 $19 Million
Q1 2021 May 17, 2021	BUY	$16.71 - $19.9 $8.74 Million - $10.4 Million	523,298 Added 51.49%	1,539,585 $28.1 Million
Q4 2020 Feb 16, 2021	BUY	$15.39 - $18.97 $8.52 Million - $10.5 Million	553,550 Added 119.63%	1,016,287 $18.5 Million
Q3 2020 Nov 16, 2020	BUY	$17.1 - $19.19 $1.1 Million - $1.24 Million	64,450 Added 16.18%	462,737 $8.26 Million
Q2 2020 Aug 14, 2020	SELL	$14.59 - $19.5 $3.5 Million - $4.68 Million	-239,967 Reduced 37.6%	398,287 $7.14 Million
Q1 2020 May 15, 2020	BUY	$13.02 - $20.31 $6.29 Million - $9.81 Million	483,226 Added 311.7%	638,254 $9.69 Million
Q4 2019 Feb 14, 2020	SELL	$16.88 - $20.83 $930,256 - $1.15 Million	-55,110 Reduced 26.23%	155,028 $3.06 Million
Q3 2019 Nov 14, 2019	BUY	$16.15 - $17.99 $1.43 Million - $1.59 Million	88,327 Added 72.51%	210,138 $3.61 Million
Q2 2019 Aug 16, 2019	BUY	$16.58 - $20.49 $2.02 Million - $2.5 Million	121,811 New	121,811 $2.16 Million

Others Institutions Holding TAK

# of Institutions

337

Shares Held

73.8M

Call Options Held

1.96M

Put Options Held

165K

View Full List

About TAKEDA PHARMACEUTICAL CO LTD

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $42.2B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

More about TAK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Takeda Pharmaceutical CO LTD Transaction History